Cyclooxygenase expression in the early stages of equine laminitis: a cytologic study.
暂无分享,去创建一个
[1] D. Busija,et al. Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties , 2005, Journal of Pharmacology and Experimental Therapeutics.
[2] V. Klauss,et al. Selective COX-2 Inhibitors and Risk of Myocardial Infarction , 2005, Journal of Vascular Research.
[3] G. S. Shelness,et al. Cloning and Characterization of Cyclooxygenase-1b (Putative Cyclooxygenase-3) in Rat , 2005, Journal of Pharmacology and Experimental Therapeutics.
[4] J. Frøkiaer,et al. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus. , 2005, American journal of physiology. Renal physiology.
[5] S. Reina,et al. Signal transduction underlying carbachol-induced PGE2 generation and cox-1 mRNA expression of rat brain , 2005, Neuropharmacology.
[6] A. Blikslager,et al. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. , 2005, Research in veterinary science.
[7] S. Keller,et al. Kupffer cell ablation attenuates cyclooxygenase-2 expression after trauma and sepsis. , 2005, The Journal of surgical research.
[8] B. McGorum,et al. Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease. , 2010, Equine veterinary journal.
[9] C. Pollitt,et al. Equine laminitis: loss of hemidesmosomes in hoof secondary epidermal lamellae correlates to dose in an oligofructose induction model: an ultrastructural study. , 2010, Equine veterinary journal.
[10] R. Kemppainen,et al. Increased expression of MAIL, a cytokine-associated nuclear protein, in the prodromal stage of black walnut-induced laminitis. , 2010, Equine veterinary journal.
[11] C. Pollitt,et al. Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. , 2010, Equine veterinary journal.
[12] J. Belknap,et al. Expression of the cyclooxygenase isoforms in the prodromal stage of black walnut-induced laminitis in horses. , 2004, American journal of veterinary research.
[13] P. Toutain,et al. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. , 2004, Journal of veterinary pharmacology and therapeutics.
[14] J. Daly,et al. Enhanced expression of cyclooxygenase-2 and prostaglandin E2 in response to endotoxin after trauma is dependent on MAPK and NF-kappaB mechanisms. , 2004, Cellular immunology.
[15] S. Ashley,et al. Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2 , 2004, Cancer Research.
[16] P. Conzen,et al. Selective Inhibition of Cyclooxygenase-2 Enhances Platelet Adhesion in Hamster Arterioles In Vivo , 2004, Circulation.
[17] B. Hinz,et al. Pain and osteoarthritis: new drugs and mechanisms , 2004, Current opinion in rheumatology.
[18] H. Haller,et al. Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression. , 2004, Biochemical and biophysical research communications.
[19] N. Davies,et al. Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3. , 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[20] K. Westover,et al. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. , 2004, American journal of veterinary research.
[21] J. Mitchell,et al. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] L. Kopelovich,et al. Cyclooxygenases in the skin: pharmacological and toxicological implications. , 2003, Toxicology and applied pharmacology.
[23] A. Mügge,et al. Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertension , 2003, Journal of hypertension.
[24] R. Mahajan,et al. Non-selective and cyclo-oxygenase-2-specific non-steroidal anti-inflammatory drugs impair the hyperaemic response of skin to brief axillary artery occlusion. , 2003, British journal of anaesthesia.
[25] N. V. Chandrasekharan,et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Schuligoi,et al. Role of cyclooxygenase-2 in gastric mucosal defense. , 2001, Life sciences.
[27] J. Moore,et al. Expression of interleukin-1beta in the digital laminae of horses in the prodromal stage of experimentally induced laminitis. , 2001, American journal of veterinary research.
[28] T. Hökfelt,et al. Cyclooxygenase-1 and cyclooxygenase-2 expression in rat kidney and adrenal gland after stimulation with systemic lipopolysaccharide , 2001, Cell and Tissue Research.
[29] V. Ganjam,et al. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis. , 2010, Equine veterinary journal.
[30] J. Morrow,et al. Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells* , 2000, The Journal of Biological Chemistry.
[31] Thomas M. McIntyre,et al. Post-transcriptional Control of Cyclooxygenase-2 Gene Expression , 2000, The Journal of Biological Chemistry.
[32] L. Marnett,et al. Effects of nitric oxide and nitric oxide‐derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] J. Pepper,et al. Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[34] C. Leffler,et al. Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells. , 1998, American journal of physiology. Cell physiology.
[35] L. Crofford,et al. COX-1 and COX-2 tissue expression: implications and predictions. , 1997, The Journal of rheumatology. Supplement.
[36] M. Kasuga,et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. , 1997, Gastroenterology.
[37] E. Sigal,et al. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. , 1996, British journal of rheumatology.
[38] P. Isakson,et al. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. , 1996, The Journal of clinical investigation.
[39] J. Maclouf,et al. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. , 1996, Experimental cell research.
[40] M. Goldyne,et al. Endogenous prostaglandin E2 modulates calcium-induced differentiation in human skin keratinocytes. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.
[41] J. Moore,et al. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. , 1990, American journal of veterinary research.